Compounded with
Semaglutide
Not verified in the bound record.
Tirzepatide
Not verified in the bound record.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
The Wellness Center Pharmacy, Inc. dba Designer Drugs
Not verified in the bound record.
Not verified in the bound record.
Product evidence does not establish current availability.
Regulatory compliance
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
FDA's 2019 referral says the firm apparently obtained prescriptions for identified patients as required by section 503A.
Section 503B
not found in current fda registry check
Telehealth providers
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
FDA warning/closeout, state-referral, Form 483/current-503B and Tennessee board sources were checked. The 2016 warning/2019 closeout and 2019 referral were verified; no later state order was recovered.
U.S. Food and Drug Administration · 2016-08-05
FDA later stated that the firm appeared to have adequately addressed the violations in this warning letter.
closed_out_2019-02-06U.S. Food and Drug Administration · 2019-02-06
After a December 2017 inspection, FDA referred poor sterile-practice concerns to Tennessee. FDA listed media-fill, contamination and cleaning concerns, stated that the deviations appeared readily correctable, and said FDA did not intend further action at that time regarding that inspection.
Status not statedNo Clinic Scout patient reviews are published for this pharmacy. Submissions go through manual moderation before anything appears here.
What this record verifies for you
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
No superiority claim is made for review volume, ratings, or patient sentiment.
Our specialities range from hormone replacement therapy, dermatologics, and weight loss to sexual health, mental health, vitamins, and hydration.
FDA has completed an evaluation of your firm’s corrective actions in response to our warning letter #2016-NOL-11 dated August 5, 2016. Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter.
The purpose of this letter is to refer to the Tennessee State Board of Pharmacy (BOP) for appropriate follow up, the U.S. Food and Drug Administration’s (FDA) concerns about poor sterile practices observed during an FDA inspection at ... The Wellness Center Pharmacy, Inc., dba Designer Drugs
After review of the record, FDA does not intend to take further action at this time with regard to the findings of this inspection ... FDA is referring this matter to the Tennessee BOP for follow up to ensure appropriate corrective action is taken.
Updated as of 8/18/2026 ... This table lists the outsourcing facilities that have submitted registration information that has been determined to be complete by the data lock date for the latest weekly update of the table.
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 5 dated first-party or regulator citation(s), 2 regulatory/action record(s), and 6 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.
Weekly price watch
One useful comparison each week. No spam, no sold lists, and you can unsubscribe anytime.